Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Design Therapeutics, Inc. | President and CEO, Director | Stock Option (right to buy) | 415K | Feb 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DSGN | Design Therapeutics, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 3, 2023 | President and CEO, Director |
DSGN | Design Therapeutics, Inc. | Dec 19, 2022 | 2 | $62.5K | 4 | Dec 21, 2022 | President and CEO, Director |
DSGN | Design Therapeutics, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 2, 2022 | President and CEO, Director |